1944 Journal of Natural Products, 2007, Vol. 70, No. 12
Paranagama et al.
was removed under reduced pressure, and the crude product was purified
by preparative TLC (silica gel) using CH2Cl2/MeOH (95:5) as eluant
to give 3,5-di-O-methylcytosporone F (8.6 mg).
under reduced pressure to afford cytosporone C (3.0 mg). Its 1H NMR
and MS data were consistent with those reported in the literature.10
Conversion of Cytosporone F (1) to Aposphaerin B (9).
p-Toluenesulfonic acid (0.1 mg) was added to a stirred solution of 1
(2.0 mg) in dry toluene (0.5 mL), and the reaction mixture was heated
at 65 °C for 2 h (TLC control). Toluene was removed under reduced
pressure, and the crude mixture was dissolved in CH2Cl2/MeOH
(90:10). The solution was passed through a short bed of silica gel using
CH2Cl2/MeOH (9:1) (10 mL). The solvents were evaporated under
3,5-Di-O-methylcytosporone F (16): pale brown oil; UV (EtOH)
max (log ε) 279 (5.68), 213 (5.57) nm; IR νmax 2925, 1735, 1602, 1460,
λ
1157 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.94 (1H, dd, J ) 15.4 and
10.8 Hz, H-3′), 6.41 (1H, d, J ) 2.2 Hz, H-6), 6.38 (1H, d, J ) 2.2
Hz, H-4), 6.35 (1H, d, J ) 15.4 Hz, H-2′), 6.21 (1H, dd, J ) 15.1 and
10.8 Hz, H-4′), 6.12 (1H, dt, J ) 15.1 and 6.9 Hz, H-5′), 4.06 (2H, q,
J ) 7.1 Hz, H-1′′), 3.80 (3H, s, OCH3), 3.74 (3H, s, OCH3), 3.55 (2H,
s, H-7), 2.12 (2H, m, H-6′), 1.41 (2H, dq, J ) 14.8 and 7.4 Hz, H-7′),
1.18 (3H, t, J ) 7.1 Hz, H-2′′), 0.89 (3H, t, J ) 7.4 Hz, H-8′); 13C
NMR (125 MHz, CDCl3) δ 196.2 (C, C-1′), 171.1 (C, C-8), 161.2 (C,
C-3), 158.6 (C, C-5), 145.4 (CH, C-5′), 143.4 (CH, C-3′), 134.6 (C,
C-1), 130.3 (CH, C-2′), 129.3 (CH, C-4′), 113.9 (C, C-2), 107.3 (CH,
C-6), 97.6 (CH, C-4), 60.8 (CH2, C-1′′), 55.8 (CH3, OCH3), 55.4 (CH3,
OCH3), 38.7 (CH2, C-7), 35.2 (CH2, C-6′), 21.9 (CH2, C-7′), 14.2 (CH3,
C-2′′), 13.6 (C, C-8′); HRFABMS m/z 347.1860 [M + 1]+ (calcd for
C20H27O5, 347.1858).
1
reduced pressure to afford aphosphaerin B (2.0 mg). Its H NMR and
MS data were consistent with those reported in the literature.13
Monocillin III (7): white solid; 1H NMR, 13C NMR, and MS data
were consistent with those reported in the literature.14
Preparation of the (R)- and (S)-MTPA Ester Derivatives of
Cytosporone H (3) by a Convenient Mosher Ester Procedure.15
Compound 3 (0.5 mg) was transferred into a clean NMR tube and was
dried under vacuum. Pyridine-d5 (0.6 mL) and (R)-(-)-R-methoxy-R-
(trifluoromethyl)phenylacetyl chloride (5 µL) were added into the NMR
tube immediately under a stream of dry N2, and then the NMR tube
was shaken carefully to mix the sample and MTPA chloride evenly.
The reaction mixture in the NMR tube was allowed to stand at room
temperature, and the 1H NMR was recorded after 6 h. 1H NMR data of
the (S)-MTPA ester derivative (21a) of 3 (500 MHz, pyridine-d5): δ
6.459 (1H, d, J ) 15.1 Hz, H-2′), 6.316 (1H, m, H-4′), 6.127 (1H, m,
H-5′), 5.277 (1H, m, H-7′), 4.040 (2H, q, J ) 7.1 Hz, H-1′′), 3.905
(2H, s, H-7), 2.450 (2H, m, H-6′), 1.178 (3H, d, J ) 6.2 Hz, H-8′),
1.051 (3H, t, J ) 7.1 Hz, H-2′′). In the manner described for 21a,
another portion of 3 (0.5 mg) was reacted in a second NMR tube with
(S)-(-)-R-methoxy-R-(trifluoromethyl)phenylacetyl chloride (5 µL) at
room temperature for 6 h using pyridine-d5 (0.5 mL) as solvent to afford
Catalytic Hydrogenation of 3,5-Di-O-methylcytosporone F (16).
A solution of 16 (8.0 mg) in EtOH (0.5 mL) containing 10% Pd on
carbon (1 mg) was stirred in an atmosphere of H2 for 3 h (TLC control).
The solution was filtered through a plug of cotton, and the solvent was
evaporated under reduced pressure. The crude product was purified by
preparative TLC (silica gel) using CH2Cl2/i-PrOH (99:1) as eluant to
give 3,5-di-O-methylcytosporone B (17) (5.3 mg).
3,5-Di-O-methylcytosporone B (17): colorless oil; UV (EtOH) λmax
(log ε) 283 (6.00), 226 (5.97) nm; IR νmax 2927, 1735, 1681, 1317,
1
1155 cm-1; H NMR (500 MHz, CDCl3) δ 6.37 (1H, d, J ) 2.3 Hz,
H-6), 6.36 (1H, d, J ) 2.3 Hz, H-4), 4.12 (2H, q, J ) 7.1 Hz, H-1′′),
3.79 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.59 (2H, s, H-7), 2.80 (2H,
t, J ) 7.4 Hz, H-2′), 1.62 (2H, m, H-3′), 1.26 (8H, m, H-4′-H-7′),
1.23 (3H, t, J ) 7.1 Hz, H-2′′), 0.86 (3H, t, J ) 7.4 Hz, H-8′); 13C
NMR (125 MHz, CDCl3) δ 206.9 (C, C-1′), 171.2 (C, C-8), 161.2 (C,
C-3), 158.7 (C, C-5), 134.4 (C, C-1), 124.3 (C, C-2), 107.7 (CH, C-6),
97.5 (CH, C-4), 60.9 (CH2, C-1′′), 55.6 (CH3, OCH3), 55.4 (CH3,
OCH3), 44.5 (CH2, C-2′), 38.9 (CH2, C-7), 31.6 (CH2, C-6′), 29.3 (CH2,
C-4′), 29.1 (CH2, C-5′), 24.1 (CH2, C-3′), 22.6 (CH2, C-7′), 14.2 (CH3,
C-2′′), 14.1 (CH3, C-8′); HRFABMS m/z 351.2186 [M + 1]+ (calcd
for C20H31O5, 351.2171).
1
the (R)-MTPA ester derivative (21b) of 3. H NMR data of 21b (500
MHz, pyridine-d5): δ 6.426 (1H, d, J ) 15.1 Hz, H-2′), 6.204 (1H, m,
H-4′), 5.917 (1H, m, H-5′), 5.288 (1H, m, H-7′), 4.042 (2H, q, J ) 7.1
Hz, H-1′′), 3.905 (2H, s, H-7), 2.386 (2H, m, H-6′), 1.255 (3H, d, J )
6.2 Hz, H-8′), 1.053 (3H, t, J ) 7.1 Hz, H-2′′).
Effect of Metal Ions on the Production of Monocillin I (8). PDB
(50 mL) was prepared with distilled water into each 250 mL conical
flask, and appropriate weights of CuSO4, ZnSO4, Cd(NO3)2, and
K2Cr2O7, were added into each flask separately to obtain the final
concentrations of 0.5 mM CuSO4, 0.5 mM ZnSO4, 0.125 mM Cd(NO3)2,
and 0.0125 mM K2Cr2O7. The spore solutions (1 mL) prepared as above
were added into each flask and shaken on a rotary shaker at 160 rpm
and 28 °C. The experiment with each metal ion concentration was
carried out in triplicate. After two weeks the supernatant was extracted
into EtOAc (3 × 50 mL) and concentrated to dryness. Each EtOAc
extract was analyzed using reversed-phase HPLC, and the percentage
of monocillin I produced by each culture was estimated.
Cultivation, Extraction, and Isolation of Metabolites of Chaeto-
mium chiWersii. A culture of C. chiVersii grown on PDA for one week
was used for inoculation. Mycelia were scraped out and mixed with
sterile PDB (150 mL) and filtered through a 100 µm filter to separate
spores from the mycelia. Absorbance of the spore solution was
measured and adjusted to between 0.5 and 0.3. This spore solution (50
mL) was used to inoculate 2 L Erlenmeyer flasks containing 1.0 L of
PDB prepared with filtered water. Flasks were shaken on a rotary shaker
at 28 °C and 160 rpm for one week. On day 7, mycelia were separated
from the supernatant by filtering through Whatman No. 1 filter paper.
The supernatant was neutralized to pH 7 and extracted with EtOAc (8
× 500 mL). The lyophilized mycelia (20.0 g) were extracted with
EtOAc (8 × 500 mL) and the EtOAc extracts evaporated under reduced
pressure to afford a dark green semisolid (2.1 g). A portion (1.8 g) of
this extract was partitioned between hexane and 80% aqueous MeOH.
Evaporation of solvents under reduced pressure yielded hexane (1.02
g) and 80% aqueous MeOH (0.77 g) fractions. The 80% aqueous MeOH
fraction was diluted with water to 50% aqueous MeOH and extracted
with CHCl3. Evaporation of CHCl3 under reduced pressure yielded a
brown semisolid (0.71 g), which was subjected to column chromatog-
raphy on a column of LiChroprep DIOL (22 g, 25–40 µm) made up in
hexane (100 mL) and eluted with hexane and mixtures of hexane/
CH2Cl2 of increasing polarity, CH2Cl2, mixtures of CH2Cl2/MeOH of
increasing polarity, and finally with MeOH. A total of 55 fractions
(7.5 mL each) were collected, and fractions having similar TLC
behavior were combined to give 17 subfractions. Of these, the
subfraction 12 afforded chaetochromin A (12) (157.9 mg), the major
Reduction of 3,5-Di-O-methylcytosporone F (17) with NaBH4.
NaBH4 (5 mg) was added to a stirred solution of 17 (5.0 mg) in
anhydrous MeOH (0.5 mL) at 0 °C. After 5 min, the ice bath was
removed and the reaction mixture was stirred at room temperature until
the starting material disappeared (TLC control). It was then filtered,
the solvent was removed under reduced pressure, and the crude product
was purified by preparative TLC (silica gel) using CH2Cl2/i-PrOH
(99:1) as eluant to give 3,5-dimethoxy-2-(1′-hydroxyoctyl)phenethyl
alcohol (19) (3.9 mg) as a colorless oil: UV (EtOH) λmax (log ε) 283
(5.64), 227 (5.55), 214 (5.52) nm; IR νmax 3427, 2925, 1602, 1460,
1147 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.37 (1H, d, J ) 2.4, H-6),
6.32 (1H, d, J ) 2.4 Hz, H-4), 4.83 (1H, dd, J ) 8.6 and 5.5 Hz,
H-1′), 3.83 (2H, t, J ) 6.4 Hz, H-8), 3.82 (3H, s, OCH3), 3.72 (3H, s,
OCH3), 2.89 (2H, t, J ) 6.4 Hz, H-7), 1.95 (1H, m, H-2′a), 1.67 (1H,
m, H-2′b), 1.26 (10H, m, H-3′-H-7′), 0.85 (3H, t, J ) 7.4 Hz, H-8′);
13C NMR (125 MHz, CDCl3) δ 159.2 (C, C-3), 158.9 (C, C-5), 137.6
(C, C-1), 123.5 (C, C-2), 106.9 (CH, C-6), 97.7 (CH, C-4), 70.5 (CH2,
C-8), 63.5 (CH, C-1′), 55.4 (CH3, OCH3), 55.3 (CH3, OCH3), 37.8 (CH2,
C-7), 36.8 (CH2, C-2′), 31.9 (CH2, C-6′), 29.6 (CH2, C-4′), 29.3 (CH2,
C-5′), 26.3 (CH2, C-3′), 22.7 (CH2, C-7′), 14.1 (CH3, C-8′); HRFABMS
m/z 293.2125 [MH - H2O]+ (calcd for C18H29O3, 293.2117).
Conversion of Cytosporone F (1) to Cytosporone B (18).
A
solution of 1 (3.0 mg) in EtOH (0.5 mL) containing Pd on carbon (10%,
1 mg) was stirred in an atmosphere of H2 for 2 h (TLC control). The
solution was filtered through a plug of cotton, and the solvent was
evaporated under reduced pressure to afford cytosporone B (18) as a
white solid (3.0 mg). Its 1H NMR, 13C NMR, and MS data were
consistent with those reported in the literature.10
Conversion of Cytosporone F (1) to Cytosporone C (20).
A
solution of 1 (3.0 mg) in 0.2 N NaOH (0.5 mL) was stirred with NaBH4
(3.0 mg) at room temperature for 1 h (TLC control). The reaction
mixture was acidified by adding an appropriate amount of 2 N HCl at
0 °C. After 5 min the ice bath was removed and the aqueous solution
was extracted with EtOAc (2 × 10 mL). The solvent was evaporated